CHM 0.00% 1.7¢ chimeric therapeutics limited

Ann: Successful Completion of First Patient Cohort Phase 1 Trial, page-8

  1. 58 Posts.
    lightbulb Created with Sketch. 8
    So no reports of any major side affects indicating safe for administration.
    Very very encouraging.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.